Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-20-000636
Filing Date
2020-03-04
Accepted
2020-03-04 14:30:15
Documents
1
Period of Report
2020-01-30

Document Format Files

Seq Description Document Type Size
1 form4a-03042020_020302.html 4/A  
1 form4a-03042020_020302.xml 4/A 8182
  Complete submission text file 0001415889-20-000636.txt   9825
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address
WEAVER GREGORY L (Reporting) CIK: 0001251779 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31326 | Film No.: 20686733